LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 51

Search options

  1. Article ; Online: Role of T Cells in Chikungunya Virus Infection and Utilizing Their Potential in Anti-Viral Immunity.

    Poh, Chek Meng / Chan, Yi-Hao / Ng, Lisa F P

    Frontiers in immunology

    2020  Volume 11, Page(s) 287

    Abstract: Chikungunya virus (CHIKV) is an arthropod-borne alphavirus that causes hallmark debilitating polyarthralgia, fever, and rash in patients. T cell-mediated immunity, especially ... ...

    Abstract Chikungunya virus (CHIKV) is an arthropod-borne alphavirus that causes hallmark debilitating polyarthralgia, fever, and rash in patients. T cell-mediated immunity, especially CD4
    MeSH term(s) Animals ; Arthralgia ; Chikungunya Fever/immunology ; Chikungunya virus/physiology ; Disease Progression ; Exanthema ; Humans ; Immunologic Memory ; T-Lymphocyte Subsets/immunology ; T-Lymphocytes/immunology
    Language English
    Publishing date 2020-02-21
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2020.00287
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The trinity of COVID-19

    Tay, Matthew Zirui / Poh, Chek Meng / Rénia, Laurent / MacAry, Paul A. / Ng, Lisa F. P.

    Nature Reviews Immunology

    immunity, inflammation and intervention

    2020  Volume 20, Issue 6, Page(s) 363–374

    Keywords Immunology ; covid19
    Language English
    Publisher Springer Science and Business Media LLC
    Publishing country us
    Document type Article ; Online
    ZDB-ID 2062776-2
    ISSN 1474-1741 ; 1474-1733
    ISSN (online) 1474-1741
    ISSN 1474-1733
    DOI 10.1038/s41577-020-0311-8
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: The trinity of COVID-19: immunity, inflammation and intervention.

    Tay, Matthew Zirui / Poh, Chek Meng / Rénia, Laurent / MacAry, Paul A / Ng, Lisa F P

    Nature reviews. Immunology

    2020  Volume 20, Issue 6, Page(s) 363–374

    Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic. Alongside investigations into the virology of SARS-CoV-2, understanding the fundamental physiological and ... ...

    Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic. Alongside investigations into the virology of SARS-CoV-2, understanding the fundamental physiological and immunological processes underlying the clinical manifestations of COVID-19 is vital for the identification and rational design of effective therapies. Here, we provide an overview of the pathophysiology of SARS-CoV-2 infection. We describe the interaction of SARS-CoV-2 with the immune system and the subsequent contribution of dysfunctional immune responses to disease progression. From nascent reports describing SARS-CoV-2, we make inferences on the basis of the parallel pathophysiological and immunological features of the other human coronaviruses targeting the lower respiratory tract - severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Finally, we highlight the implications of these approaches for potential therapeutic interventions that target viral infection and/or immunoregulation.
    MeSH term(s) Animals ; Betacoronavirus/immunology ; Betacoronavirus/physiology ; COVID-19 ; Coronavirus Infections/immunology ; Coronavirus Infections/physiopathology ; Coronavirus Infections/therapy ; Coronavirus Infections/virology ; Disease Progression ; Humans ; Inflammation/etiology ; Inflammation/immunology ; Pandemics ; Pneumonia, Viral/immunology ; Pneumonia, Viral/physiopathology ; Pneumonia, Viral/therapy ; Pneumonia, Viral/virology ; SARS-CoV-2
    Keywords covid19
    Language English
    Publishing date 2020-04-28
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2062776-2
    ISSN 1474-1741 ; 1474-1733
    ISSN (online) 1474-1741
    ISSN 1474-1733
    DOI 10.1038/s41577-020-0311-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Heterosubtypic Protection Induced by a Live Attenuated Influenza Virus Vaccine Expressing Galactose-α-1,3-Galactose Epitopes in Infected Cells.

    Yan, Li-Meng / Lau, Sylvia P N / Poh, Chek Meng / Chan, Vera S F / Chan, Michael C W / Peiris, Malik / Poon, Leo L M

    mBio

    2020  Volume 11, Issue 2

    Abstract: Anti-galactose-α-1,3-galactose (anti-α-Gal) antibody is naturally expressed at a high level in humans. It constitutes about 1% of immunoglobulins found in human blood. Here, we designed a live attenuated influenza virus vaccine that can generate α-Gal ... ...

    Abstract Anti-galactose-α-1,3-galactose (anti-α-Gal) antibody is naturally expressed at a high level in humans. It constitutes about 1% of immunoglobulins found in human blood. Here, we designed a live attenuated influenza virus vaccine that can generate α-Gal epitopes in infected cells in order to facilitate opsonization of infected cells, thereby enhancing vaccine-induced immune responses. In the presence of normal human sera, cells infected with this mutant can enhance phagocytosis of human macrophages and cytotoxicity of NK cells
    MeSH term(s) Animals ; Cross Reactions/immunology ; Epitopes/immunology ; Galactose/immunology ; Humans ; Immunogenicity, Vaccine ; Influenza A virus/classification ; Influenza A virus/immunology ; Influenza Vaccines/genetics ; Influenza Vaccines/immunology ; Killer Cells, Natural/immunology ; Macrophages/immunology ; Mice ; Mice, Inbred BALB C ; Mice, Knockout ; Orthomyxoviridae Infections/prevention & control ; Vaccines, Attenuated/genetics ; Vaccines, Attenuated/immunology
    Chemical Substances Epitopes ; Influenza Vaccines ; Vaccines, Attenuated ; Galactose (X2RN3Q8DNE)
    Language English
    Publishing date 2020-03-03
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2557172-2
    ISSN 2150-7511 ; 2161-2129
    ISSN (online) 2150-7511
    ISSN 2161-2129
    DOI 10.1128/mBio.00027-20
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Activated Brain Endothelial Cells Cross-Present Malaria Antigen.

    Shanshan W Howland / Chek Meng Poh / Laurent Rénia

    PLoS Pathogens, Vol 11, Iss 6, p e

    2015  Volume 1004963

    Abstract: In the murine model of cerebral malaria caused by P. berghei ANKA (PbA), parasite-specific CD8+ T cells directly induce pathology and have long been hypothesized to kill brain endothelial cells that have internalized PbA antigen. We previously reported ... ...

    Abstract In the murine model of cerebral malaria caused by P. berghei ANKA (PbA), parasite-specific CD8+ T cells directly induce pathology and have long been hypothesized to kill brain endothelial cells that have internalized PbA antigen. We previously reported that brain microvessel fragments from infected mice cross-present PbA epitopes, using reporter cells transduced with epitope-specific T cell receptors. Here, we confirm that endothelial cells are the population responsible for cross-presentation in vivo, not pericytes or microglia. PbA antigen cross-presentation by primary brain endothelial cells in vitro confers susceptibility to killing by CD8+ T cells from infected mice. IFNγ stimulation is required for brain endothelial cross-presentation in vivo and in vitro, which occurs by a proteasome- and TAP-dependent mechanism. Parasite strains that do not induce cerebral malaria were phagocytosed and cross-presented less efficiently than PbA in vitro. The main source of antigen appears to be free merozoites, which were avidly phagocytosed. A human brain endothelial cell line also phagocytosed P. falciparum merozoites. Besides being the first demonstration of cross-presentation by brain endothelial cells, our results suggest that interfering with merozoite phagocytosis or antigen processing may be effective strategies for cerebral malaria intervention.
    Keywords Immunologic diseases. Allergy ; RC581-607 ; Biology (General) ; QH301-705.5
    Language English
    Publishing date 2015-06-01T00:00:00Z
    Publisher Public Library of Science (PLoS)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: Activated Brain Endothelial Cells Cross-Present Malaria Antigen.

    Howland, Shanshan W / Poh, Chek Meng / Rénia, Laurent

    PLoS pathogens

    2015  Volume 11, Issue 6, Page(s) e1004963

    Abstract: In the murine model of cerebral malaria caused by P. berghei ANKA (PbA), parasite-specific CD8+ T cells directly induce pathology and have long been hypothesized to kill brain endothelial cells that have internalized PbA antigen. We previously reported ... ...

    Abstract In the murine model of cerebral malaria caused by P. berghei ANKA (PbA), parasite-specific CD8+ T cells directly induce pathology and have long been hypothesized to kill brain endothelial cells that have internalized PbA antigen. We previously reported that brain microvessel fragments from infected mice cross-present PbA epitopes, using reporter cells transduced with epitope-specific T cell receptors. Here, we confirm that endothelial cells are the population responsible for cross-presentation in vivo, not pericytes or microglia. PbA antigen cross-presentation by primary brain endothelial cells in vitro confers susceptibility to killing by CD8+ T cells from infected mice. IFNγ stimulation is required for brain endothelial cross-presentation in vivo and in vitro, which occurs by a proteasome- and TAP-dependent mechanism. Parasite strains that do not induce cerebral malaria were phagocytosed and cross-presented less efficiently than PbA in vitro. The main source of antigen appears to be free merozoites, which were avidly phagocytosed. A human brain endothelial cell line also phagocytosed P. falciparum merozoites. Besides being the first demonstration of cross-presentation by brain endothelial cells, our results suggest that interfering with merozoite phagocytosis or antigen processing may be effective strategies for cerebral malaria intervention.
    MeSH term(s) Animals ; Antigen Presentation/immunology ; Antigens, Protozoan/immunology ; Brain/immunology ; Brain/parasitology ; CD8-Positive T-Lymphocytes/immunology ; Cell Line ; Cross-Priming/immunology ; Disease Models, Animal ; Endothelial Cells/immunology ; Fluorescent Antibody Technique ; Humans ; Malaria, Cerebral/immunology ; Mice ; Mice, Inbred C57BL
    Chemical Substances Antigens, Protozoan
    Language English
    Publishing date 2015-06
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2205412-1
    ISSN 1553-7374 ; 1553-7366
    ISSN (online) 1553-7374
    ISSN 1553-7366
    DOI 10.1371/journal.ppat.1004963
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Multiplex Screening Assay for Identifying Cytotoxic CD8

    Poh, Chek Meng / Zheng, Jian / Channappanavar, Rudragouda / Chang, Zi Wei / Nguyen, Thi H O / Rénia, Laurent / Kedzierska, Katherine / Perlman, Stanley / Poon, Leo L M

    Frontiers in immunology

    2020  Volume 11, Page(s) 400

    Abstract: The cytotoxicity of epitope-specific ... ...

    Abstract The cytotoxicity of epitope-specific CD8
    MeSH term(s) Animals ; Epitopes, T-Lymphocyte/immunology ; Epitopes, T-Lymphocyte/isolation & purification ; Flow Cytometry/methods ; Humans ; Mice ; Staining and Labeling/methods ; T-Lymphocytes, Cytotoxic/immunology
    Chemical Substances Epitopes, T-Lymphocyte
    Keywords covid19
    Language English
    Publishing date 2020-03-11
    Publishing country Switzerland
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2020.00400
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: The trinity of COVID-19: immunity, inflammation and intervention

    Tay, Matthew Zirui / Poh, Chek Meng / Rénia, Laurent / MacAry, Paul A / Ng, Lisa F P

    Nat. rev. immunol

    Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic. Alongside investigations into the virology of SARS-CoV-2, understanding the fundamental physiological and ... ...

    Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic. Alongside investigations into the virology of SARS-CoV-2, understanding the fundamental physiological and immunological processes underlying the clinical manifestations of COVID-19 is vital for the identification and rational design of effective therapies. Here, we provide an overview of the pathophysiology of SARS-CoV-2 infection. We describe the interaction of SARS-CoV-2 with the immune system and the subsequent contribution of dysfunctional immune responses to disease progression. From nascent reports describing SARS-CoV-2, we make inferences on the basis of the parallel pathophysiological and immunological features of the other human coronaviruses targeting the lower respiratory tract - severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Finally, we highlight the implications of these approaches for potential therapeutic interventions that target viral infection and/or immunoregulation.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #32346093
    Database COVID19

    Kategorien

  9. Article ; Online: Combined use of live-attenuated and inactivated influenza vaccines to enhance heterosubtypic protection.

    Yan, Li-Meng / Li, Olive T W / Poh, Chek M / Perera, Ranawaka A P M / Valkenburg, Sophie A / Peiris, Malik / Poon, Leo L M

    Virology

    2018  Volume 525, Page(s) 73–82

    Abstract: The limited protection of current commerical vaccines necessitates the investigation of novel vaccine strategies for unpredictable outbreaks. To investigate the feasibility of using vaccines derived from Group 1 influenza A virus to induce broadly cross- ... ...

    Abstract The limited protection of current commerical vaccines necessitates the investigation of novel vaccine strategies for unpredictable outbreaks. To investigate the feasibility of using vaccines derived from Group 1 influenza A virus to induce broadly cross-reactive immune responses against multiple influenza subtypes, we tested a panel of sequential 4-dose immunization regimens in mice. Mice were treated with inactivated (seasonal H1N1, pandemic H1N1 and H5N1) and vaccinia virus-based H5N1 live-attenuated vaccines in different combinations. Mice were then challenged by viruses of either Group 1 (H1N1) or Group 2 (H3N2, H7N7) influenza virus. All studied sequential 4-dose vaccinations could induce some degrees of heterosubtypic protection in mice. Amongst all these regimens, the combined use of inactivated and live-attenuated vaccines could achieve the best heterologous protection. These results highlight the synergistic effect of combining different vaccine platforms to enhance heterosubtypic protection against influenza viruses.
    MeSH term(s) Animals ; Antigens, Viral ; Female ; Influenza Vaccines/administration & dosage ; Influenza Vaccines/immunology ; Mice ; Mice, Inbred BALB C ; Orthomyxoviridae Infections/prevention & control ; Vaccines, Attenuated/administration & dosage ; Vaccines, Attenuated/immunology ; Vaccines, Inactivated/administration & dosage ; Vaccines, Inactivated/immunology
    Chemical Substances Antigens, Viral ; Influenza Vaccines ; Vaccines, Attenuated ; Vaccines, Inactivated
    Language English
    Publishing date 2018-09-21
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 200425-2
    ISSN 1096-0341 ; 0042-6822
    ISSN (online) 1096-0341
    ISSN 0042-6822
    DOI 10.1016/j.virol.2018.09.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Interferon regulatory factor 1 is essential for pathogenic CD8+ T cell migration and retention in the brain during experimental cerebral malaria.

    Gun, Sin Yee / Claser, Carla / Teo, Teck Hui / Howland, Shanshan W / Poh, Chek Meng / Chye, Rebecca Ren Ying / Ng, Lisa F P / Rénia, Laurent

    Cellular microbiology

    2018  Volume 20, Issue 5, Page(s) e12819

    Abstract: Host immune response has a key role in controlling the progression of malaria infection. In the well-established murine model of experimental cerebral malaria (ECM) with Plasmodium berghei ANKA infection, proinflammatory Th1 and CD8+ T cell response are ... ...

    Abstract Host immune response has a key role in controlling the progression of malaria infection. In the well-established murine model of experimental cerebral malaria (ECM) with Plasmodium berghei ANKA infection, proinflammatory Th1 and CD8+ T cell response are essential for disease development. Interferon regulatory factor 1 (IRF1) is a transcription factor that promotes Th1 responses, and its absence was previously shown to protect from ECM death. Yet the exact mechanism of protection remains unknown. Here we demonstrated that IRF1-deficient mice (IRF1 knockout) were protected from ECM death despite displaying early neurological signs. Resistance to ECM death was a result of reduced parasite sequestration and pathogenic CD8+ T cells in the brain. Further analysis revealed that IRF1 deficiency suppress interferon-γ production and delayed CD8+ T cell proliferation. CXCR3 expression was found to be decreased in pathogenic CD8+ T cells, which limited their migration to the brain. In addition, reduced expression of adhesion molecules by brain endothelial cells hampered leucocyte retention in the brain. Taken together, these factors limited sequestration of pathogenic CD8+ T cells and consequently its ability to induce extensive damage to the blood-brain barrier.
    MeSH term(s) Animals ; Brain/microbiology ; Brain/pathology ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/microbiology ; Cell Movement/genetics ; Disease Models, Animal ; Gene Expression Regulation ; Humans ; Interferon Regulatory Factor-1/genetics ; Lymphocyte Activation/genetics ; Lymphocyte Activation/immunology ; Malaria, Cerebral/genetics ; Malaria, Cerebral/immunology ; Malaria, Cerebral/microbiology ; Mice ; Mice, Knockout ; Plasmodium berghei/pathogenicity ; Receptors, CXCR3/genetics
    Chemical Substances Cxcr3 protein, mouse ; Interferon Regulatory Factor-1 ; Irf1 protein, mouse ; Receptors, CXCR3
    Language English
    Publishing date 2018-01-18
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1468320-9
    ISSN 1462-5822 ; 1462-5814
    ISSN (online) 1462-5822
    ISSN 1462-5814
    DOI 10.1111/cmi.12819
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top